Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04947319
Title Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ono Pharmaceutical Co. Ltd
Indications

central nervous system lymphoma

Therapies

Tirabrutinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.